Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
Express Scripts
Medtronic
Dow

Last Updated: December 7, 2021

Volunteer for clinical trials for dasiglucagon hydrochloride at ClinicalTrialExchange

DrugPatentWatch Database Preview

Dasiglucagon hydrochloride - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic sources for dasiglucagon hydrochloride and what is the scope of freedom to operate?

Dasiglucagon hydrochloride is the generic ingredient in two branded drugs marketed by Zealand Pharma and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Dasiglucagon hydrochloride has thirty-one patent family members in twenty-three countries.

Summary for dasiglucagon hydrochloride
International Patents:31
US Patents:1
Tradenames:2
Applicants:1
NDAs:1
Clinical Trials: 17
DailyMed Link:dasiglucagon hydrochloride at DailyMed
Recent Clinical Trials for dasiglucagon hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Filip Krag KnopPhase 2
Steno Diabetes Center CopenhagenPhase 2
University Hospital Inselspital, BerneEarly Phase 1

See all dasiglucagon hydrochloride clinical trials

US Patents and Regulatory Information for dasiglucagon hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zealand Pharma ZEGALOGUE dasiglucagon hydrochloride SOLUTION;SUBCUTANEOUS 214231-001 Mar 22, 2021 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y Y ⤷  Try it Free
Zealand Pharma ZEGALOGUE (AUTOINJECTOR) dasiglucagon hydrochloride SOLUTION;SUBCUTANEOUS 214231-002 Mar 22, 2021 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y Y ⤷  Try it Free
Zealand Pharma ZEGALOGUE dasiglucagon hydrochloride SOLUTION;SUBCUTANEOUS 214231-001 Mar 22, 2021 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Zealand Pharma ZEGALOGUE (AUTOINJECTOR) dasiglucagon hydrochloride SOLUTION;SUBCUTANEOUS 214231-002 Mar 22, 2021 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Moodys
Harvard Business School
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.